Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Cohn

Showing results (21-30 of 183) with videos related to

Pageof 19
Sort By:
Pediatric Blood & Cancer|January 24, 2006
Collection, storage, and infusion of stem cells in children with high-risk neuroblastoma: saving for a rainy dayStephan A Grupp, Susan L Cohn, Donna Wall, et al.
Lancet (London, England)|June 26, 2007
NeuroblastomaJohn M Maris, Michael D Hogarty, Rochelle Bagatell, et al.
Journal of Pediatric Hematology/Oncology Nursing|September 21, 2022
The Experience of Children With Neuroblastoma and Their Parents During Single-Room Isolation for <sup>131</sup>I-Metaiodobenzylguanidine Therapy: A Qualitative Descriptive StudyCynthia M LaFond, Alyssa Yost, Kelly Lankin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2008
Management of tumor lysis syndrome: need for evidence-based guidelinesJames H Feusner, A Kim Ritchey, Susan L Cohn, et al.
Expert Opinion on Orphan Drugs|October 25, 2017
Emerging and investigational therapies for neuroblastomaMark A Applebaum, Ami V Desai, Julia L Glade Bender, et al.
Archives of Pathology & Laboratory Medicine|June 25, 2005
Protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumorsStephen J Qualman, Jay Bowen, Patrick L Fitzgibbons, et al.
Pediatric Blood & Cancer|December 3, 2013
Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observationNavin Pinto, Douglas A Cipkala, Patricia E Ladd, et al.
Pediatric Blood & Cancer|November 18, 2004
Positive association between congenital anomalies and risk of neuroblastomaFlorence Menegaux, Andrew F Olshan, Pamela J Reitnauer, et al.
Cancer Genetics and Cytogenetics|April 25, 2007
High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor genePrakash N Nair, Linda McArdle, John Cornell, et al.
Pediatric Blood & Cancer|July 26, 2020
Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patientsErin K Barr, Kathryn Laurie, Kristen Wroblewski, et al.
Pageof 19

Showing results (21-30 of 183) with videos related to

Sort By:
Pageof 19
Pediatric Blood & Cancer|January 24, 2006
Collection, storage, and infusion of stem cells in children with high-risk neuroblastoma: saving for a rainy dayStephan A Grupp, Susan L Cohn, Donna Wall, et al.
Lancet (London, England)|June 26, 2007
NeuroblastomaJohn M Maris, Michael D Hogarty, Rochelle Bagatell, et al.
Journal of Pediatric Hematology/Oncology Nursing|September 21, 2022
The Experience of Children With Neuroblastoma and Their Parents During Single-Room Isolation for <sup>131</sup>I-Metaiodobenzylguanidine Therapy: A Qualitative Descriptive StudyCynthia M LaFond, Alyssa Yost, Kelly Lankin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2008
Management of tumor lysis syndrome: need for evidence-based guidelinesJames H Feusner, A Kim Ritchey, Susan L Cohn, et al.
Expert Opinion on Orphan Drugs|October 25, 2017
Emerging and investigational therapies for neuroblastomaMark A Applebaum, Ami V Desai, Julia L Glade Bender, et al.
Archives of Pathology & Laboratory Medicine|June 25, 2005
Protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumorsStephen J Qualman, Jay Bowen, Patrick L Fitzgibbons, et al.
Pediatric Blood & Cancer|December 3, 2013
Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observationNavin Pinto, Douglas A Cipkala, Patricia E Ladd, et al.
Pediatric Blood & Cancer|November 18, 2004
Positive association between congenital anomalies and risk of neuroblastomaFlorence Menegaux, Andrew F Olshan, Pamela J Reitnauer, et al.
Cancer Genetics and Cytogenetics|April 25, 2007
High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor genePrakash N Nair, Linda McArdle, John Cornell, et al.
Pediatric Blood & Cancer|July 26, 2020
Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patientsErin K Barr, Kathryn Laurie, Kristen Wroblewski, et al.
Pageof 19